IMIST


In vitro and in vivo evaluatin of anti-diabetic and anti-inflammatory activity of asparagus aphyllus L., Crataegus azarolus L., and Ephedra alata Decne.: (notice n° 58001)

000 -LEADER
fixed length control field 05467nam a2200517 i 4500
003 - CONTROL NUMBER IDENTIFIER
control field IMIST
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20221005111129.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220912s2017 mr 000 0 eng
040 ## - CATALOGING SOURCE
Original cataloging agency IMIST
Language of cataloging fre
Transcribing agency IMIST
Description conventions rda
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title eng
044 ## - COUNTRY OF PUBLISHING/PRODUCING ENTITY CODE
MARC country code MA
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 22
Classification number 615.3
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 22
Classification number 615.1
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Edition number 22
Classification number 616.462
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Kmail, Abdalsalam Omer
9 (RLIN) 210631
Relator term Auteur
245 10 - TITLE STATEMENT
Title In vitro and in vivo evaluatin of anti-diabetic and anti-inflammatory activity of asparagus aphyllus L., Crataegus azarolus L., and Ephedra alata Decne.:
Statement of responsibility, etc Abdalsalam Omer , Kmail
Remainder of title From traditional uses to cellular action mechanisms/
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc Fés
Name of publisher, distributor, etc Université Sidi Mohamed Ben Abdellah
Date of publication, distribution, etc 2016
264 #0 - Production, Publication, Distribution, Manufacture, and Copyright Notice
Place of production, publication, distribution, manufacture Fés
Name of producer, publisher, distributor, manufacturer Université Sidi Mohammed Ben Abdellah - Fès
Date of production, publication, distribution, manufacture, or copyright notice 2016
300 ## - PHYSICAL DESCRIPTION
Extent 149 pages
336 ## - CONTENT TYPE
Source rdacontent
Content Type Term text
Content Type Code txt
337 ## - MEDIA TYPE
Source rdamedia
Media Type Term unmediated
Media Type Code n
338 ## - CARRIER TYPE
Source rdacarrier
Carrier Type Term volume
Carrier Type Code nc
500 ## - GENERAL NOTE
General note Souleimani, Abdalah (Presedent)||Lyoussi, Badiaa (Thesis Supervisor)||Saad, Bashar (Thesis Cosupervisor)||EL Idrissi EL Azami, Mohammed (Thesis Cosupervisor)||EL Idrissi EL Azami, Mohammed (Reporter)||ES-Safi, Nour Eddine (Reporter)||El Jaziri, Mondher (Reporter)||Lamchouri, Fatima (Examiner)||Diouri, Mohammed (Examiner)||Abdellaoui, Abdelfattah (Examiner)
502 ## - DISSERTATION NOTE
Degree type PH.D -
Year degree granted 2016
Name of granting institution Université Sidi Mohammed Ben Abdellah - Fès
520 ## - SUMMARY, ETC.
Summary, etc There is a strong consideration that diabetes is accompanied by low grade inflammation. Both, diabetes and inflammation, lead to cardiovascular complications. Due to the well-known side- effects inherent in the available synthetic drugs presently used at clinics, there is a need for novel and efficient anti-diabetes and anti-inflammatory herbal-based drug candidates with reduced side effects. The aim of this study was to identify effective non-toxic anti-inflammatory as well as anti-oxidant and anti-diabetic medicinal plant extracts. Based on knowledge from traditional Greco-Arab and Islamic herbal medicine, we have selected three potential plants, Asparagus aphyllus L., (AA) Crataegus azarolus L., (CA) and Ephedra alata Decne. (EA). The first part of the study is focused on the extraction and assessment of cytotoxic and cytostatic effects of the plant extracts as well as in determination of non toxic concentrations of the plant extracts using both monoculture and coculture systems of cells from the hepatocyte cell line (HepG2) and cells from the monocyte cell line (THP-1) and their co-cultures. Both culture systems were treated with increasing concentration of the three plant extracts. Results obtained in this phase indicate that the three extracts are safe up to 125 μg/ml and that traditionally known anti-cancer properties of Crataegus azarolus L. and Ephedra alata Decne. extracts might be mediated, at least in part, through cytostatic effects. Furthermore, it seems that the observed increased cytostatic effects in the co-culture compared to monoculture system are mediated through macrophage-derived factors produced after activation of these cells by the plant extracts. The second part of the study is focused on the evaluation of antioxidant and anti-inflammatory properties of the plant extracts through measurements of pro-inflammatory and anti- inflammatory cytokines. Results obtained indicate that three plants extracts contain relatively high levels of phenols and significant antioxidant activities as measured with RP, DPPH, and ABTS. In addition to the observed significant antioxidant capacity, they regulate the production of pro-inflammatory as well as anti-inflammatory cytokines. The third part aimed to measure the anti-diabetic effects of plant extracts with positive anti- inflammatory effects through assessment of insulin secretion and GLUT4 translocation. The in vivo evaluation of hypoglycemic effects of five plant water/ethanol extracts showed that three plants exhibit potintial antidiabetic activities. Results obtained with GLUT4 Plasma membrane translocation assay and in vivo tests indicates that AA and AE plant extracts may downregulate blood glucose by improving GLUT4 membrane translocation in a concentration dependent manner at nontoxic concentrations. These experiments are steps forwards the identification of novel safe drugs for curing diabetes and inflammation by medicinal plants. Taken collectively, results obtained here using in vitro and in vivo test suggest that the traditionally known antidiabetic and anti-inflammatory properties of the three plants seem to be mediated, at least in part, through upregulation of GLUT4 plasma membrane translocation and downregulation of proinflammatory cytokine, respectively.
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term Antidiabetic
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term Anti-inflammatory
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term Antioxidant
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term Cytotostatic
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term Cytotoxic
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term pharmacology
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term physiology
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term environmental health
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term asparagus aphyllus L.
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term Crataegus azarolus L.
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term diabetes
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term inflammation
653 1# - INDEX TERM--UNCONTROLLED
Uncontrolled term Islamic herbal medicine
700 1# - MEMBRES DE JURY
Personal name EL Idrissi EL Azami, Mohammed
9 (RLIN) 210632
700 ## - MEMBRES DE JURY
Personal name Lyoussi, Badiaa
9 (RLIN) 203554
Relator term Directeur de thèse
700 ## - MEMBRES DE JURY
Personal name Bashar, Saad
9 (RLIN) 210359
Relator term Directeur de thèse
700 ## - MEMBRES DE JURY
Personal name Souleimani, Abdalah
9 (RLIN) 210635
Relator term Collaborateur
710 2# - ADDED ENTRY--CORPORATE NAME
Université Université Sidi Mohammed Ben Abdellah - Fès
Faculté Faculté des sciences
Relator term Directeur de production
856 4# - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://toubkal.imist.ma/handle/123456789/11485">http://toubkal.imist.ma/handle/123456789/11485</a>
Link text Voir dans Toubkal
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Thèse universitaire
Exemplaires
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Permanent Location Current Location Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          La bibliothèque des Sciences Médicales et Pharmaceutiques La bibliothèque des Sciences Médicales et Pharmaceutiques 10/05/2022   TH-615.3 KMA 0000000034732 10/05/2022 10/05/2022 Thèse universitaire
© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha